Improved quality of life in type 1 diabetes patients who had undergone pancreatic islet transplantation surgeries, was seen in a phase 3 clinical study. It was conducted by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and published online March 21 in Diabetes Care.
